Pars Plana Vitrectomy Without Intravenous Anesthesia: Technique, Safety, and Outcomes.

IF 0.5 Q4 OPHTHALMOLOGY
Journal of VitreoRetinal Diseases Pub Date : 2024-06-22 eCollection Date: 2024-09-01 DOI:10.1177/24741264241260093
Karena X Tien, Erica Romo, Murtaza K Adam
{"title":"Pars Plana Vitrectomy Without Intravenous Anesthesia: Technique, Safety, and Outcomes.","authors":"Karena X Tien, Erica Romo, Murtaza K Adam","doi":"10.1177/24741264241260093","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> To describe the technique, safety profile, and outcomes of performing pars plana vitrectomy (PPV) without intravenous (IV) anesthesia. <b>Methods:</b> This retrospective single-surgeon study comprised patients who had PPV without IV sedation between September 2018 and April 2022. Patients elected to undergo PPV without sedation or with oral sedation via sublingual triazolam administered 30 minutes preoperatively. Sub-Tenon bupivacaine and lidocaine were administered at the initiation of each case. A circulating nurse monitored patient vitals and electrocardiogram tracings without anesthesiologist support. Adverse events (AEs), visual acuity (VA), supplemental block administration, and reoperation rates were documented. <b>Results:</b> A total of 357 PPVs in 319 patients (mean age 68.75 ± 11.17 years [SD]; range, 36.82-98.57) were performed for surgical indications including vitreous floaters, intraocular lens or cataract surgery complications, retinal detachment, vitreous hemorrhage, and epiretinal membrane. Twenty-three cases were performed without sedation, and 334 were performed with oral sedation. For eyes with a follow-up longer than 1 month (n = 324), the preoperative VA of 0.68 ± 0.77 logMAR improved to 0.31 ± 0.46 logMAR postoperatively (<i>P</i> < .01). No intraoperative complications, systemic AEs, need to cease surgery prematurely, or conversion to IV sedation occurred. Five eyes (1.77%) required intraoperative supplemental sub-Tenon block administration, and 95% of patients who had a reoperation <b>(</b>n = 10) or fellow-eye surgery (n = 28) requested the same method of anesthesia without IV sedation. <b>Conclusions:</b> Vitreoretinal surgery with a sub-Tenon block and oral sedation can be safely performed without the support of an anesthesiologist. Additional trials are needed to further quantify patient comfort, surgeon experience, and complication rates.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2024-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11440523/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of VitreoRetinal Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/24741264241260093","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: To describe the technique, safety profile, and outcomes of performing pars plana vitrectomy (PPV) without intravenous (IV) anesthesia. Methods: This retrospective single-surgeon study comprised patients who had PPV without IV sedation between September 2018 and April 2022. Patients elected to undergo PPV without sedation or with oral sedation via sublingual triazolam administered 30 minutes preoperatively. Sub-Tenon bupivacaine and lidocaine were administered at the initiation of each case. A circulating nurse monitored patient vitals and electrocardiogram tracings without anesthesiologist support. Adverse events (AEs), visual acuity (VA), supplemental block administration, and reoperation rates were documented. Results: A total of 357 PPVs in 319 patients (mean age 68.75 ± 11.17 years [SD]; range, 36.82-98.57) were performed for surgical indications including vitreous floaters, intraocular lens or cataract surgery complications, retinal detachment, vitreous hemorrhage, and epiretinal membrane. Twenty-three cases were performed without sedation, and 334 were performed with oral sedation. For eyes with a follow-up longer than 1 month (n = 324), the preoperative VA of 0.68 ± 0.77 logMAR improved to 0.31 ± 0.46 logMAR postoperatively (P < .01). No intraoperative complications, systemic AEs, need to cease surgery prematurely, or conversion to IV sedation occurred. Five eyes (1.77%) required intraoperative supplemental sub-Tenon block administration, and 95% of patients who had a reoperation (n = 10) or fellow-eye surgery (n = 28) requested the same method of anesthesia without IV sedation. Conclusions: Vitreoretinal surgery with a sub-Tenon block and oral sedation can be safely performed without the support of an anesthesiologist. Additional trials are needed to further quantify patient comfort, surgeon experience, and complication rates.

无需静脉麻醉的玻璃体旁切除术:技术、安全性和结果。
简介:描述在不进行静脉(IV)麻醉的情况下实施玻璃体旁切除术(PPV)的技术、安全性和结果。方法:该回顾性单外科医师研究包括2018年9月至2022年4月期间在无静脉注射镇静的情况下进行PPV的患者。患者选择不使用镇静剂或术前30分钟通过舌下含服三唑仑口服镇静剂进行PPV手术。每个病例在开始时均使用腱膜下布比卡因和利多卡因。一名循环护士在没有麻醉师支持的情况下监测患者的生命体征和心电图描记。不良事件(AE)、视力(VA)、辅助阻滞用药和再手术率均有记录。结果:共对 319 名患者(平均年龄为 68.75±11.17 岁 [SD];范围为 36.82-98.57)进行了 357 例 PPV,手术适应症包括玻璃体漂浮物、眼内晶状体或白内障手术并发症、视网膜脱离、玻璃体出血和视网膜外膜。其中 23 例未使用镇静剂,334 例使用口服镇静剂。对于随访时间超过1个月的眼睛(n = 324),术前VA为0.68 ± 0.77 logMAR,术后改善为0.31 ± 0.46 logMAR(P(n = 10)或同眼手术(n = 28)要求采用相同的麻醉方法,不使用静脉镇静剂。结论使用腱膜下阻滞和口服镇静剂的玻璃体视网膜手术可以在没有麻醉师支持的情况下安全进行。需要进行更多的试验来进一步量化患者的舒适度、外科医生的经验和并发症发生率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.20
自引率
16.70%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信